PE20030122A1 - Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram - Google Patents
Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopramInfo
- Publication number
- PE20030122A1 PE20030122A1 PE2002000551A PE2002000551A PE20030122A1 PE 20030122 A1 PE20030122 A1 PE 20030122A1 PE 2002000551 A PE2002000551 A PE 2002000551A PE 2002000551 A PE2002000551 A PE 2002000551A PE 20030122 A1 PE20030122 A1 PE 20030122A1
- Authority
- PE
- Peru
- Prior art keywords
- citalopram
- solvents
- precipitated material
- crystalline
- preparation
- Prior art date
Links
- 229960001653 citalopram Drugs 0.000 title abstract 6
- WSEQXVZVJXJVFP-UHFFFAOYSA-N 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile Chemical compound O1CC2=CC(C#N)=CC=C2C1(CCCN(C)C)C1=CC=C(F)C=C1 WSEQXVZVJXJVFP-UHFFFAOYSA-N 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 239000002904 solvent Substances 0.000 abstract 6
- 239000000463 material Substances 0.000 abstract 4
- 239000002253 acid Substances 0.000 abstract 2
- 239000012452 mother liquor Substances 0.000 abstract 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
- 230000001376 precipitating effect Effects 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
SE REFIERE A UN PROCESO PARA LA PREPARACION DE CITALOPRAM RACEMICO EN FORMA DE UNA BASE LIBRE OBTENIDA MEDIANTE LA ADICION DE UN ACIDO (ACIDO BROMHIDRICO) QUE COMPRENDE PRECIPITAR CITALOPRAM A PARTIR DE SOLVENTES (DE PREFERENCIA SOLVENTES PROTICOS COMO AGUA, ALCOHOLES, CETONAS, SOLVENTES APROTICOS COMO ACRILONITRILO, DIGLIMA), SEPARAR EL PRECIPITADO (ACEITE, SOLIDO AMORFO, CRISTALES) FORMADO DEL LICOR MADRE (SOLVENTE QUE QUEDA DESPUES DE LA REMOCION O SEPARACION DEL MATERIAL PRECIPITADO A PARTIR DEL SOLVENTE); SI EL MATERIAL PRECIPITADO ES CRISTALINO, ES OPCIONALMENTE RECRISTALIZADO UNO O MAS VECES PARA FORMAR CITALOPRAM RACEMICO, SI EL MATERIAL PRECIPITADO NO ES CRISTALINO SE REPITEN LOS ANTERIORES PASOS O HASTA OBTENER UN MATERIAL PRECIPITADO CRISTALINO; EL LICOR MADRE ES SOMETIDO A PURIFICACION ADICIONAL
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200100991 | 2001-06-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030122A1 true PE20030122A1 (es) | 2003-02-12 |
Family
ID=8160584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000551A PE20030122A1 (es) | 2001-06-25 | 2002-06-24 | Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram |
Country Status (39)
| Country | Link |
|---|---|
| US (1) | US7112686B2 (es) |
| EP (1) | EP1412341B1 (es) |
| JP (2) | JP4377219B2 (es) |
| KR (4) | KR100939945B1 (es) |
| CN (2) | CN100429208C (es) |
| AR (2) | AR034612A1 (es) |
| AT (1) | ATE284395T1 (es) |
| BG (1) | BG66372B1 (es) |
| BR (1) | BRPI0210574B8 (es) |
| CA (2) | CA2691149C (es) |
| CO (1) | CO5550420A2 (es) |
| CZ (1) | CZ305034B6 (es) |
| DE (1) | DE60202216T2 (es) |
| DK (1) | DK1412341T3 (es) |
| EA (1) | EA006446B1 (es) |
| ES (1) | ES2233834T3 (es) |
| HR (1) | HRP20031075B1 (es) |
| HU (1) | HU228476B1 (es) |
| IL (1) | IL159229A0 (es) |
| IS (1) | IS2426B (es) |
| JO (1) | JO2389B1 (es) |
| MA (1) | MA26260A1 (es) |
| ME (2) | ME00027B (es) |
| MX (1) | MXPA03011770A (es) |
| MY (1) | MY133471A (es) |
| NO (2) | NO329873B1 (es) |
| NZ (1) | NZ530104A (es) |
| PE (1) | PE20030122A1 (es) |
| PL (1) | PL366560A1 (es) |
| PT (1) | PT1412341E (es) |
| RS (1) | RS50673B (es) |
| SI (1) | SI1412341T1 (es) |
| SK (1) | SK287696B6 (es) |
| TN (1) | TNSN02062A1 (es) |
| TW (1) | TWI236473B (es) |
| UA (1) | UA75147C2 (es) |
| UY (2) | UY27356A1 (es) |
| WO (1) | WO2003000672A1 (es) |
| ZA (1) | ZA200309633B (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20040991A1 (es) | 2002-08-12 | 2004-12-27 | Lundbeck & Co As H | Separacion de intermediarios para la preparacion de escitalopram |
| EA013116B1 (ru) | 2002-12-23 | 2010-02-26 | Х. Лундбекк А/С | Эсциталопрамгидробромид, его применение и фармкомпозиция |
| CN100334071C (zh) * | 2002-12-23 | 2007-08-29 | H·隆德贝克有限公司 | 外消旋西酞普兰二醇和 /或 s －或 r－西酞普兰二醇的制备方法及这些二醇在制备外消旋西酞普兰二醇、 r －西酞普兰和 /或 s －西酞普兰中的用途 |
| CA2511143C (en) | 2002-12-23 | 2011-06-28 | H. Lundbeck A/S | Preparation of racemic and/or s- or r-citalopram diols and their use for the preparation racemic and/or s- or r-citalopram |
| AU2003223105A1 (en) * | 2003-03-24 | 2004-10-18 | Hetero Drugs Limited | Novel crystalline forms of (s)-citalopram oxalate |
| CN100569765C (zh) * | 2003-12-19 | 2009-12-16 | 杭州民生药业集团有限公司 | 西酞普兰中间体晶体碱 |
| TWI339651B (en) | 2004-02-12 | 2011-04-01 | Lundbeck & Co As H | Method for the separation of intermediates which may be used for the preparation of escitalopram |
| CA2558198A1 (en) * | 2004-03-05 | 2005-09-15 | H. Lundbeck A/S | Crystalline composition containing escitalopram oxalate |
| US20050196453A1 (en) | 2004-03-05 | 2005-09-08 | H. Lundbeck A/S | Crystalline composition containing escitalopram |
| ITMI20040717A1 (it) | 2004-04-09 | 2004-07-09 | Adorkem Technology Spa | Procedimento chemo-enzimatico per la preparazione dell'escitalopram |
| JP2006008603A (ja) * | 2004-06-25 | 2006-01-12 | Sumitomo Chemical Co Ltd | 光学活性シタロプラムの製造方法、その中間体およびその製造方法 |
| US7989645B2 (en) * | 2004-08-23 | 2011-08-02 | Sun Pharma Global Fze | Process for preparation of citalopram and enantiomers |
| EP2141156A1 (en) * | 2004-08-23 | 2010-01-06 | Sun Pharma Global FZE | Process for Preparation of Citalopram and Enantiomers |
| US20110196032A1 (en) * | 2005-05-20 | 2011-08-11 | Ashish Gogia | Pharmaceutical Dosage Form of an Antidepressant |
| US7834201B2 (en) | 2005-06-22 | 2010-11-16 | H. Lundbeck A/S | Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
| TWI347942B (en) * | 2005-06-22 | 2011-09-01 | Lundbeck & Co As H | Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
| EA200801081A1 (ru) | 2005-10-14 | 2008-10-30 | Х. Лундбекк А/С | Способы лечения расстройств центральной нервной системы комбинацией малых доз эсциталопрама и бупропиона |
| WO2008059514A2 (en) * | 2006-07-31 | 2008-05-22 | Cadila Healthcare Limited | Process for preparing escitalopram |
| US8022232B2 (en) * | 2007-09-11 | 2011-09-20 | H. Lundbeck A/S | Method for manufacture of escitalopram |
| FI121570B (fi) | 2007-09-11 | 2011-01-14 | Lundbeck & Co As H | Menetelmä essitalopraamin valmistamiseksi |
| CN100548974C (zh) * | 2007-10-11 | 2009-10-14 | 浙江大学 | 西酞普兰中间体的萃取分离方法 |
| CN101560199B (zh) * | 2008-04-16 | 2013-09-18 | 北京德众万全药物技术开发有限公司 | 一种依地普仑的制备方法 |
| TWI381813B (zh) | 2010-01-12 | 2013-01-11 | Taiwan Paiho Ltd | A Velcro assembly for a foamed article and a foamed article comprising the adhesive tape assembly |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8419963D0 (en) * | 1984-08-06 | 1984-09-12 | Lundbeck & Co As H | Intermediate compound and method |
| GB8814057D0 (en) * | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
| SK287140B6 (sk) * | 1999-10-25 | 2010-01-07 | H. Lundbeck A/S | Spôsob prípravy citalopramu a medziprodukt na jeho výrobu |
-
2002
- 2002-06-21 AR ARP020102350A patent/AR034612A1/es active IP Right Grant
- 2002-06-23 JO JO200265A patent/JO2389B1/en active
- 2002-06-24 PE PE2002000551A patent/PE20030122A1/es active IP Right Grant
- 2002-06-24 TN TNTNSN02062A patent/TNSN02062A1/en unknown
- 2002-06-25 ES ES02742848T patent/ES2233834T3/es not_active Expired - Lifetime
- 2002-06-25 MY MYPI20022382A patent/MY133471A/en unknown
- 2002-06-25 KR KR1020097004586A patent/KR100939945B1/ko not_active Expired - Lifetime
- 2002-06-25 HU HU0400293A patent/HU228476B1/hu unknown
- 2002-06-25 KR KR1020087026708A patent/KR20080100498A/ko not_active Ceased
- 2002-06-25 KR KR1020037016853A patent/KR100902530B1/ko not_active Expired - Lifetime
- 2002-06-25 WO PCT/DK2002/000426 patent/WO2003000672A1/en not_active Ceased
- 2002-06-25 RS YUP-1014/03A patent/RS50673B/sr unknown
- 2002-06-25 CN CNB028126688A patent/CN100429208C/zh not_active Expired - Lifetime
- 2002-06-25 ME MEP-2008-15A patent/ME00027B/me unknown
- 2002-06-25 HR HR20031075A patent/HRP20031075B1/xx not_active IP Right Cessation
- 2002-06-25 MX MXPA03011770A patent/MXPA03011770A/es active IP Right Grant
- 2002-06-25 KR KR1020107006751A patent/KR20100052550A/ko not_active Ceased
- 2002-06-25 NZ NZ530104A patent/NZ530104A/en not_active IP Right Cessation
- 2002-06-25 US US10/482,000 patent/US7112686B2/en not_active Expired - Lifetime
- 2002-06-25 SK SK51-2004A patent/SK287696B6/sk unknown
- 2002-06-25 PT PT02742848T patent/PT1412341E/pt unknown
- 2002-06-25 CA CA2691149A patent/CA2691149C/en not_active Expired - Fee Related
- 2002-06-25 PL PL02366560A patent/PL366560A1/xx not_active Application Discontinuation
- 2002-06-25 CA CA2450890A patent/CA2450890C/en not_active Expired - Fee Related
- 2002-06-25 BR BRPI0210574A patent/BRPI0210574B8/pt not_active IP Right Cessation
- 2002-06-25 IL IL15922902A patent/IL159229A0/xx active IP Right Grant
- 2002-06-25 CN CN2008102158851A patent/CN101440079B/zh not_active Expired - Lifetime
- 2002-06-25 AT AT02742848T patent/ATE284395T1/de active
- 2002-06-25 TW TW091113845A patent/TWI236473B/zh not_active IP Right Cessation
- 2002-06-25 EP EP02742848A patent/EP1412341B1/en not_active Expired - Lifetime
- 2002-06-25 MA MA26713A patent/MA26260A1/fr unknown
- 2002-06-25 UA UA20031211986A patent/UA75147C2/uk unknown
- 2002-06-25 DE DE60202216T patent/DE60202216T2/de not_active Expired - Lifetime
- 2002-06-25 JP JP2003507077A patent/JP4377219B2/ja not_active Expired - Lifetime
- 2002-06-25 ME MEP-15/08A patent/MEP1508A/xx unknown
- 2002-06-25 UY UY27356A patent/UY27356A1/es not_active IP Right Cessation
- 2002-06-25 SI SI200230078T patent/SI1412341T1/xx unknown
- 2002-06-25 DK DK02742848T patent/DK1412341T3/da active
- 2002-06-25 CZ CZ2004-131A patent/CZ305034B6/cs not_active IP Right Cessation
- 2002-06-25 EA EA200400082A patent/EA006446B1/ru not_active IP Right Cessation
-
2003
- 2003-12-08 IS IS7068A patent/IS2426B/is unknown
- 2003-12-11 ZA ZA2003/09633A patent/ZA200309633B/en unknown
- 2003-12-18 NO NO20035671A patent/NO329873B1/no not_active IP Right Cessation
-
2004
- 2004-01-14 BG BG108532A patent/BG66372B1/bg unknown
- 2004-01-22 CO CO04004620A patent/CO5550420A2/es not_active Application Discontinuation
-
2009
- 2009-04-17 JP JP2009101188A patent/JP5064436B2/ja not_active Expired - Lifetime
-
2010
- 2010-10-13 NO NO20101420A patent/NO335106B1/no not_active IP Right Cessation
-
2011
- 2011-10-19 AR ARP110103869A patent/AR083483A2/es active IP Right Grant
-
2014
- 2014-11-21 UY UY0001035850A patent/UY35850A/es not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20030122A1 (es) | Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram | |
| MX2021012680A (es) | Metodos para la produccion de monohidrato de l-glufosinato de amonio cristalino. | |
| AR038902A1 (es) | Proceso para mejorar la pureza y el rendimiento de la sucralosa | |
| ES2191628T3 (es) | Procedimiento para extraccion y purificacion de paclitaxel a partir de fuentes naturales. | |
| JP2009502906A (ja) | エソメプラゾール及びその塩の製造方法 | |
| AR046309A1 (es) | Derivados de dihidrobenzofuranilo alcanamina, metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de trastornos del sistema nervioso central. | |
| JP2004536093A5 (ja) | Ｒ−及びｓ−シタロプラムの混合物を分離することによってラセミシタロプラム及びｓ−もしくはｒ−シタロプラムを製造する方法 | |
| AR013051A1 (es) | Aislacion y purificacion de esteroles a partir de fracciones neutras de resina de tallol mediante cristalizacion de decantacion unica | |
| CN1578761A (zh) | 坦洛新的拆分方法 | |
| BR112012020252B1 (pt) | processo para a preparação de nebivolol | |
| BRPI0407336A (pt) | Processos para produzir uma mistura de ácido carboxìlico/diol, e uma mistura de ácido tereftálico/diol | |
| BR0309357A (pt) | Método para fabricar cristais de esteróides, cristais obtìveis de acordo com esse método, e formulações farmacêuticas | |
| EP1581483A1 (en) | A PROCESS FOR THE PREPARATION OF RACEMIC CITALOPRAM DIOL AND/OR i S- /i OR i R- /i CITALOPRAM DIOLS AND THE USE OF SUCH DIOLS FOR THE PREPARATION OF RACEMIC CITALOPRAM, i R- /i CITALOPRAM AND/OR i S- /i CITALOPRAM | |
| AR046229A1 (es) | Procesos para la preparacion de cefalosporina 3-(2-vinilo sustituido) altamente pura | |
| BR102013004752A2 (pt) | Processo para a transformação de medetomidina e recuperação do enantiômero indesejado | |
| BR0113035A (pt) | Método para produção de cristais de tagatose | |
| Ishizuka et al. | An efficient method for the preparation of enantiomerically pure N-acylarylsulfonamides having an asymmetric center at the α-position: Condensation of acid chlorides and arylsulfonamides under solid-liquid two-phase conditions | |
| CA2516811A1 (en) | Improved process for isolation and purification of paclitaxel from natural sources | |
| CN107108607B (zh) | 制备吡喹酮的方法 | |
| ES2385975T3 (es) | Procedimiento para la preparación de citalopram diol racémico y/o S- O R-citalopram dioles y el uso de tales dioles para la preparación de citalopram racémico, R-citalopram y/o S-citalopram | |
| ATE412623T1 (de) | Verfahren zur reinigung von bisphenol-a | |
| AR118693A1 (es) | Métodos para producir l-glufosinato de amonio monohidrato cristalino | |
| ES2058270T3 (es) | Procedimiento para purificar 4-aminofenol impuro. | |
| DE602005013382D1 (de) | Feste formen des magnesiumsalzes von (s)-omeprazol und verfahren zu deren herstellung | |
| RU2019104860A (ru) | Способ разделения солей баклофена |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal | ||
| FG | Grant, registration |